Will McCarthy

Most recently Will was CBO at Generation Bio, where he helped drive corporate strategy initiatives including the company's ~$1B IPO. Previously he was CBO at Ignyta, where he was responsible for all aspects of commercial launch planning for the company's lead clinical asset, and was a key participant in the acquisition by Roche for ~$2B. Earlier in his career he led business development and marketing functions at Foundation Medicine, Halozyme and Neurocrine. He has an MBA from London Business School and a BA in Economics.